Studies show that aspirin can reduce the risk of cancer

A researcher in the UK, Peter Rothwell from the John Radcliffe Hospital and University of Oxford reported that aspirin has been shown to significantly reduce the risk of death from various cancers.

The team of researchers in England found that people who consume low-dose aspirin (75 mg) every day, at least five years will reduce the risk of death from cancer by 60 percent.

The study involved more than 25,500 patients, by giving low dose aspirin on heart patients. The drug is proven to prevent strokes and heart attacks. Low-dose aspirin has also been shown to reduce the risk of colorectal cancer deaths.

These findings prove that the risk of overall cancer deaths declined by 21 percent in patients taking low-dose aspirin.